Approval of Mounjaro, the world’s first sustained release GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes in Japan

September 26, 2022

Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Group, has announced the following press release.

■Mitsubishi Tanabe Pharma　Press Release